news

What kind of peptide factory can win the trust of global giants? In today's world where peptides have become the core raw material for medicine, health, and beauty, the true industry powerhouses have already broken through international barriers and become the preferred choice for global partners with hard core technology, strict quality control, and innovative models.

The confidence of top peptide factories lies in disruptive technology. Some have overcome the PICT peptide information compression technology, reducing the synthesis cost of a single peptide molecule from tens of thousands of yuan to less than a penny, and building a super large peptide physical library of 10 ¹ ², shortening the development cycle of new drugs by half and increasing the success rate to 50%; Some of them are deeply engaged in the field of marine biological peptides, transforming fish scales and skin into highly active collagen peptides with biological autolytic enzyme technology, winning the the State Technological Innovation Award, and ranking first in the industry with an annual production capacity of 3000 tons. From directed enzyme digestion to synthetic biology modification, these technological breakthroughs enable peptide products to achieve a dual advantage of "efficient mass production+precise customization".

Strict quality control and international certification are hardcore endorsements. The top factories not only pass international standards certifications such as cGMP and EU GMP, but also undergo rigorous due diligence by a team of 70 global pharmaceutical companies, submitting 20000 pages of English materials to respond to over 200 queries. From raw material screening to finished product testing, the entire chain follows the ICH Q7 standard, and products such as semaglutide have been registered with the US FDA, smoothly entering the global high-end market.

The integration of industry, academia, and research with full chain services enables value to be realized. These factories, in collaboration with universities, have established innovation platforms and have accumulated nearly 200 patents. They not only provide standardized raw materials, but also customize formulas for specific needs such as joint health in Southeast Asia and sports nutrition in Europe and America. Nowadays, their products have entered the supply chain of well-known brands such as Tongrentang, and have become partners of international giants such as Novartis and Eli Lilly, empowering the health industry in all aspects from marine peptide raw materials to targeted anti-cancer drugs.

By breaking through technological barriers and establishing trust through quality, such peptide factories are rewriting the global peptide industry landscape, allowing "Chinese peptides" to gain core discourse power on the international stage.